RT @JVentoMD
@TumorBoardTues @brian_rini @montypal @PGrivasMDPhD @rafee_talukder @shilpaonc @DrYukselUrun @TiansterZhang @KidneyCancer @HHammersMD @arihakimi @RCCadvocate @QingZhangLab @DrRanaMcKay @DrScottHaake @MVossMD @archie_hh @DrTanWP @mtsiatas @sonpavde #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt

🧐 Which of the following is a post-operative prediction model which provides a review of expected oncological outcomes in patients with #RCC?

RT @JVentoMD
@TumorBoardTues @brian_rini @montypal @PGrivasMDPhD @rafee_talukder @shilpaonc @DrYukselUrun @TiansterZhang @KidneyCancer @HHammersMD @arihakimi @RCCadvocate @QingZhangLab @DrRanaMcKay @DrScottHaake @MVossMD @archie_hh @DrTanWP @mtsiatas @sonpavde #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt

🧐 Which of the following is a post-operative prediction model which provides a review of expected oncological outcomes in patients with #RCC?

RT @JVentoMD
@TumorBoardTues @brian_rini @montypal @PGrivasMDPhD @rafee_talukder @shilpaonc @DrYukselUrun @TiansterZhang @KidneyCancer @HHammersMD @arihakimi @RCCadvocate @QingZhangLab @DrRanaMcKay @DrScottHaake @MVossMD @archie_hh @DrTanWP @mtsiatas @sonpavde #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt

🧐 Which of the following is a post-operative prediction model which provides a review of expected oncological outcomes in patients with #RCC?

RT @JVentoMD
@TumorBoardTues @brian_rini @montypal @PGrivasMDPhD @rafee_talukder @shilpaonc @DrYukselUrun @TiansterZhang @KidneyCancer @HHammersMD @arihakimi @RCCadvocate @QingZhangLab @DrRanaMcKay @DrScottHaake @MVossMD @archie_hh @DrTanWP @mtsiatas @sonpavde #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt

🧐 Which of the following is a post-operative prediction model which provides a review of expected oncological outcomes in patients with #RCC?

RT @DAielloMD
#PostTest Q2️⃣ #TumorBoardTuesday
👉🏽Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt
🧐What’s cause of discordant 🧬findings btwn ctDNA & tissue molecular 🧪 in pt with recur #NSCLC post definitive ☢️ w ➕ EGFR exon 19 del on 🔬 bx but ctDNA shows ATM G1016R mutation (VAF 0.1%)?

RT @DAielloMD
#PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval http://integrityce.com/tbtEval
👉🏽ALL CME http://integrityce.com/tbt

🤔@DrSteveMartin @DAielloMD taught us ctDNA🧬utility in #NSCLC test your🧠with CME❓

🧐What would U do
80yo🚭
path-confirmed mSCC
TPS 1%
R🫁 mass
R fem lytic lesion - RORIF?

RT @DAielloMD
#PostTest Q2️⃣ #TumorBoardTuesday
👉🏽Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt
🧐What’s cause of discordant 🧬findings btwn ctDNA & tissue molecular 🧪 in pt with recur #NSCLC post definitive ☢️ w ➕ EGFR exon 19 del on 🔬 bx but ctDNA shows ATM G1016R mutation (VAF 0.1%)?

RT @DAielloMD
#PostTest Q2️⃣ #TumorBoardTuesday
👉🏽Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt
🧐What’s cause of discordant 🧬findings btwn ctDNA & tissue molecular 🧪 in pt with recur #NSCLC post definitive ☢️ w ➕ EGFR exon 19 del on 🔬 bx but ctDNA shows ATM G1016R mutation (VAF 0.1%)?

RT @DAielloMD
#PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval http://integrityce.com/tbtEval
👉🏽ALL CME http://integrityce.com/tbt

🤔@DrSteveMartin @DAielloMD taught us ctDNA🧬utility in #NSCLC test your🧠with CME❓

🧐What would U do
80yo🚭
path-confirmed mSCC
TPS 1%
R🫁 mass
R fem lytic lesion - RORIF?

Thank you @drteplinsky for an engaging #TumorBoardTuesday! Exciting to see how the treatment of #HER2 low disease is changing.

Watch for a special Friday ed of wrap up. To get ready, try your 👋🏼at the ❓s for free #CME!

---
RT @drteplinsky
#PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval🔗 http://integrityce.com/tbtEval

🤔@drteplinsky taught us progress of HER2+ low #breastcancer
🤨What would U pick for 60y👩🏻
ER+/PR-/HER2-low mBC
recent …
https://twitter.com/drteplinsky/status/1623139634694787073

RT @drteplinsky
#PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME (AMA & MOC)
🔗 http://integrityce.com/tbt

🤔What subsequent tx would you select for 👆🏽this 60yo 👩🏻 woman with ER+/PR-/HER2-low mBC if she experienced disease progression while receiving trastuzumab deruxtecan?

RT @drteplinsky
#PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval🔗 http://integrityce.com/tbtEval

🤔@drteplinsky taught us progress of HER2+ low #breastcancer
🤨What would U pick for 60y👩🏻
ER+/PR-/HER2-low mBC
recent dz prog➡️liver & pleura after 5mo paclitaxel (prev tx AI+CDK4/6i, fulv, ever+exem,&cap)

RT @TumorBoardTues
5/ Thanks #TumorBoardTuesday & #gyncsm!

🏆Claim #CME http://bit.ly/3hYxu3R
⬇️Answer #PostTest👇

🔴#PostTest Q1️⃣
📊Diarrhea, nausea, & vomiting are common GI tox associated w pembro + lenvatinib combo tx
🔴Which other tox may occur if these GI tox r not effectively managed?

RT @TumorBoardTues
6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
#CME 🔗http://bit.ly/3hYxu3R

🔴#PostTest Q 2️⃣
📊During tx w pembro + lenva, pt develops grd 3 diarrhea
🛑Lenva held
💊Loperamide Rx
Grade3️⃣diarrhea persists

🔴Which is the appropriate next step for this pt?

RT @TumorBoardTues
7/#TumorBoardTuesday #GynCSM

🔴#PostTest Q3️⃣
📊Pt receiving pembro + lenva combo for past 12m
🗓@ f/u presented w persistently high levels of TSH
🟥Lenva withheld, but TSH levels remain high (>10mIU/L)

🔴What is the most appropriate next step in the mgmt of this pt?

RT @TumorBoardTues
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

#CME🔗http://bit.ly/3hYxu3R

🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

#CME🔗http://bit.ly/3hYxu3R

🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

7/#TumorBoardTuesday #GynCSM

🔴#PostTest Q3️⃣
📊Pt receiving pembro + lenva combo for past 12m
🗓@ f/u presented w persistently high levels of TSH
🟥Lenva withheld, but TSH levels remain high (>10mIU/L)

🔴What is the most appropriate next step in the mgmt of this pt?

6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
#CME 🔗http://bit.ly/3hYxu3R

🔴#PostTest Q 2️⃣
📊During tx w pembro + lenva, pt develops grd 3 diarrhea
🛑Lenva held
💊Loperamide Rx
Grade3️⃣diarrhea persists

🔴Which is the appropriate next step for this pt?

5/ Thanks #TumorBoardTuesday & #gyncsm!

🏆Claim #CME http://bit.ly/3hYxu3R
⬇️Answer #PostTest👇

🔴#PostTest Q1️⃣
📊Diarrhea, nausea, & vomiting are common GI tox associated w pembro + lenvatinib combo tx
🔴Which other tox may occur if these GI tox r not effectively managed?